Stevanato Group S.p.A.

Stevanato Group S.p.A. designs, produces, and distributes products and processes that provide solutions for the biopharma and healthcare industries. The company operates globally, serving customers in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It is structured into two main business segments: Biopharmaceutical and Diagnostic Solutions, and Engineering. Within its Biopharmaceutical and Diagnostic Solutions segment, Stevanato Group offers a range of products including drug containment solutions such as pre-fillable syringes, cartridges, vials, and ampoules. This segment also provides in-vitro diagnostic solutions, drug delivery systems like pen injectors, auto-injectors, and wearable injectors, and diagnostic laboratory consumables. Additionally, it offers analytical and regulatory support services and medical devices. The Engineering segment focuses on providing pharmaceutical visual inspection machines, assembling and packaging machines, and glass converting machines. This segment also delivers after-sales services, which include line optimization and conversions, training, logistics, spare parts, and maintenance services. Stevanato Group also provides contract development and manufacturing services for drug delivery devices owned by its customers. The company serves a diverse client base, including pharmaceutical, biotechnology, diagnostics, and life sciences companies, as well as manufacturers of drug products, glass packaging, and fill and finish contract manufacturers. Founded in 1949, Stevanato Group S.p.A. is headquartered in Piombino Dese, Italy, and is a subsidiary of Stevanato Holding S.R.L.